TTOO Company Profile and Key Details
T2 Biosystems, Inc.
TTOO Stock Price Chart
Stock Price Today
T2 Biosystems, Inc. (TTOO) stock declined over -1.26%, trading at $0.23 on NASDAQ, down from the previous close of $0.23. The stock opened at $0.24, fluctuating between $0.21 and $0.24 in the recent session.
Stock Snapshot
Stock Price History Chart
Contact Details
About Company
T2 Biosystems, Inc., an in vitro diagnostics company, develops diagnostic products and product candidates in the United States and internationally. Its technology enables detection of pathogens, biomarkers, and other abnormalities in various unpurified patient sample types, including whole blood, plasma, serum, saliva, sputum, cerebral spinal fluid, and urine. The company also offers T2Dx Instrument, a bench-top instrument that runs various diagnostic tests from patient samples; T2Candida, a direct-from-blood test that identifies blood stream infections that causes sepsis and candidemia; T2Bacteria, a direct-from-blood test, which detects bacterial pathogens associated with sepsis; T2Resistance to identify carbapenem resistance genes; and T2SARS-CoV-2 panel to detect SARS-CoV-2 virus. In addition, it is developing T2Biothreat for detection of biothreat pathogens; comprehensive sepsis panel to detect bloodstream infections caused by bacterial and Candida species, and antibiotic resistant markers; T2Cauris to provide direct detection of the emerging superbug Candida auris in patient skin, patient blood, and hospital environmental samples; and T2Lyme, a direct-from-blood test panel designed to run on the T2Dx Instrument to identify the bacteria that cause Lyme disease. The company has collaboration agreements with Canon U.S. Life Sciences, Inc. to develop a diagnostic test panel to detect Lyme disease. T2 Biosystems, Inc. was incorporated in 2006 and is headquartered in Lexington, Massachusetts.
Company Information
| Employees | 113 |
| Beta | 0.38 |
| Sales or Revenue | $7.19M |
| 5Y Sales Change% | -0.894% |
| Fiscal Year Ends | December |
| Sector | Healthcare |
| Industry | Medical - Diagnostics & Research |
Frequently Asked Questions
T2 Biosystems, Inc. (NASDAQ: TTOO) stock price is $0.23 in the last trading session. During the trading session, TTOO stock reached the peak price of $0.24 while $0.21 was the lowest point it dropped to. The percentage change in TTOO stock occurred in the recent session was -1.26% while the dollar amount for the price change in TTOO stock was -$0.00.
The NASDAQ listed TTOO is part of Medical - Diagnostics & Research industry that operates in the broader Healthcare sector. T2 Biosystems, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.
Mr. John J. Sperzel III, B.Sc.
Pres, Chief Executive Officer & Chairman
Mr. Michael Terrence Gibbs Esq.
Senior Vice President, Gen. Counsel & Company Sec.
Dr. Roger Smith Ph.D.
Senior Vice President of Science R&D
Mr. John M. Sprague CPA
Chief Financial Officer
Dr. Aparna Jha Ahuja M.D.
Chief Medical Officer & Chairman of Scientific Advisory Board
Mr. Brett A. Giffin
Chief Commercial Officer
Mr. Alec J. Barclay
Senior Vice President
Ms. Kelley J. Morgan
Chief People Officer
TTOO's closing price is 13.86% higher than its 52-week low of $0.20 where as its distance from 52-week high of $6.95 is -96.69%.
Number of TTOO employees currently stands at 113.
Official Website of TTOO is: https://www.t2biosystems.com
TTOO could be contacted at phone 781 761 4646 and can also be accessed through its website. TTOO operates from 101 Hartwell Avenue, Lexington, MA 02421, United States.
TTOO stock volume for the day was 710.95K shares. The average number of TTOO shares traded daily for last 3 months was 1.07M.
The market value of TTOO currently stands at $6.37M with its latest stock price at $0.23 and 28.05M of its shares outstanding.
Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.
© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com